Are monoclonals the way forward to prevent or to treat ventilator-associated pneumonia in the intensive care unit?

Expert Opin Biol Ther. 2023 Jul-Dec;23(9):861-866. doi: 10.1080/14712598.2023.2240701. Epub 2023 Jul 29.

Authors

Ana Catalina Hernandez Padilla^{1

2

3}, Sylvain Meyer³, C H Van Werkhoven⁴, Marlieke Ea de Kraker⁵, Bruno François^{1

2

3}

Affiliations

¹ Inserm, Limoges, France.
² Réanimation Polyvalente, CHU Dupuytren, Limoges, France.
³ Inserm UMR 1092 and Université of Limoges, Limoges, France.
⁴ Department of Epidemiology and Health Economics, UMCU, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
⁵ Département de Médecine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.

PMID: 37498223
DOI: 10.1080/14712598.2023.2240701

No abstract available

Keywords: Antibiotic resistance; intensive care unit; monoclonal antibodies; prevention; ventilator-associated pneumonia; virulence.

Publication types

Editorial

MeSH terms

Humans
Infection Control
Intensive Care Units
Pneumonia, Ventilator-Associated* / prevention & control
Respiration, Artificial